UPLD vs. HCAT, SANG, GMGI, MAPS, TEAD, TRUE, EGAN, SSTI, PERF, and AISP
Should you be buying Upland Software stock or one of its competitors? The main competitors of Upland Software include Health Catalyst (HCAT), Sangoma Technologies (SANG), Golden Matrix Group (GMGI), WM Technology (MAPS), Teads (TEAD), TrueCar (TRUE), eGain (EGAN), SoundThinking (SSTI), Perfect (PERF), and Airship AI (AISP). These companies are all part of the "computer software" industry.
Upland Software vs. Its Competitors
Upland Software (NASDAQ:UPLD) and Health Catalyst (NASDAQ:HCAT) are both small-cap computer software companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.
Upland Software has a beta of 1.18, suggesting that its share price is 18% more volatile than the S&P 500. Comparatively, Health Catalyst has a beta of 1.46, suggesting that its share price is 46% more volatile than the S&P 500.
Health Catalyst has higher revenue and earnings than Upland Software. Health Catalyst is trading at a lower price-to-earnings ratio than Upland Software, indicating that it is currently the more affordable of the two stocks.
In the previous week, Upland Software had 4 more articles in the media than Health Catalyst. MarketBeat recorded 6 mentions for Upland Software and 2 mentions for Health Catalyst. Health Catalyst's average media sentiment score of 0.83 beat Upland Software's score of 0.42 indicating that Health Catalyst is being referred to more favorably in the news media.
Upland Software presently has a consensus target price of $4.00, indicating a potential upside of 35.14%. Health Catalyst has a consensus target price of $6.18, indicating a potential upside of 88.47%. Given Health Catalyst's higher possible upside, analysts plainly believe Health Catalyst is more favorable than Upland Software.
77.8% of Upland Software shares are owned by institutional investors. Comparatively, 85.0% of Health Catalyst shares are owned by institutional investors. 14.8% of Upland Software shares are owned by insiders. Comparatively, 2.6% of Health Catalyst shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Upland Software has a net margin of -17.49% compared to Health Catalyst's net margin of -31.67%. Health Catalyst's return on equity of -7.21% beat Upland Software's return on equity.
Summary
Health Catalyst beats Upland Software on 10 of the 16 factors compared between the two stocks.
Get Upland Software News Delivered to You Automatically
Sign up to receive the latest news and ratings for UPLD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding UPLD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Upland Software Competitors List
Related Companies and Tools
This page (NASDAQ:UPLD) was last updated on 8/22/2025 by MarketBeat.com Staff
MarketBeat All Access